Filed 4mo ago· Jan 15, 2026
28 days to disclose
Julie Johnson
DHouseTexas-32
↓sold
AbbVie
ABBV
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–29 of 29
Filed 4mo ago· Jan 15, 2026
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Common Stock
Filed 4mo ago· Jan 15, 2026
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Merck
MRK
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Stock
Filed 4mo ago· Jan 15, 2026
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Johnson & Johnson
JNJ
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Filed 4mo ago· Jan 15, 2026
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Eli Lilly
LLY
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Eli Lilly
LLY
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
AbbVie
ABBV
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Common Stock
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Merck
MRK
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Stock
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Johnson & Johnson
JNJ
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Filed 8mo ago· Sep 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Eli Lilly
LLY
$1K-$15K
+10.9% vs S&P 500
Trade dateAug 14, 2025
Filed 8mo ago· Sep 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+10.9% vs S&P 500
Trade dateAug 14, 2025
Common Stock
Filed 8mo ago· Sep 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+10.9% vs S&P 500
Trade dateAug 14, 2025
Filed 8mo ago· Sep 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Merck
MRK
$1K-$15K
+10.9% vs S&P 500
Trade dateAug 14, 2025
Stock
Filed 8mo ago· Sep 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
AbbVie
ABBV
$1K-$15K
+10.9% vs S&P 500
Trade dateAug 14, 2025
Filed 10mo ago· Jul 14, 2025
31 days to discloseJulie Johnson
DHouseTexas-32
↑bought
Merck
MRK
$1K-$15K
+29.9% vs S&P 500
Trade dateJun 13, 2025
Stock
Filed 1.1y ago· May 14, 2025
37 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Eli Lilly
LLY
$1K-$15K
+10.4% vs S&P 500
Trade dateApr 7, 2025
Filed 1.1y ago· May 14, 2025
43 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+3.6% vs S&P 500
Trade dateApr 1, 2025
Filed 1.1y ago· May 14, 2025
43 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+3.6% vs S&P 500
Trade dateApr 1, 2025
Common Stock
Filed 1.1y ago· May 14, 2025
43 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+3.6% vs S&P 500
Trade dateApr 1, 2025
Common Stock
Filed 1.1y ago· May 14, 2025
43 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Zoetis
ZTS
$1K-$15K
+3.6% vs S&P 500
Trade dateApr 1, 2025
Filed 1.1y ago· Apr 14, 2025
42 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Zoetis
ZTS
$1K-$15K
−0.7% vs S&P 500
Trade dateMar 3, 2025
Filed 1.2y ago· Mar 12, 2025
16 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Pfizer
PFE
$1K-$15K
+0.6% vs S&P 500
Trade dateFeb 24, 2025
Pfizer, Inc.
Filed 1.2y ago· Mar 12, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+1.8% vs S&P 500
Trade dateFeb 12, 2025
Common Stock
Filed 1.3y ago· Feb 12, 2025
26 days to discloseJulie Johnson
DHouseTexas-32
↑bought
Merck
MRK
$1K-$15K
+10.0% vs S&P 500
Trade dateJan 17, 2025
Stock
Filed 1.3y ago· Feb 12, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−8.2% vs S&P 500
Trade dateJan 15, 2025
Common Stock
Filed 1.3y ago· Feb 12, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↑bought
Regeneron Pharmaceuticals
REGN
$1K-$15K
−3.1% vs S&P 500
Trade dateJan 15, 2025
Common Stock
Filed 1.3y ago· Feb 12, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Moderna
MRNA
$1K-$15K
+5.6% vs S&P 500
Trade dateJan 15, 2025
Filed 1.3y ago· Feb 12, 2025
30 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Pfizer
PFE
$1K-$15K
+5.0% vs S&P 500
Trade dateJan 13, 2025
Pfizer, Inc.
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | AbbVie ABBV | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Bristol-Myers Squibb BMY Common Stock | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Merck MRK Stock | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Johnson & Johnson JNJ | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Eli Lilly LLY | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Eli Lilly LLY | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | AbbVie ABBV | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Bristol-Myers Squibb BMY Common Stock | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Merck MRK Stock | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Johnson & Johnson JNJ | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Eli Lilly LLY | Aug 14, 2025 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Bristol-Myers Squibb BMY Common Stock | Aug 14, 2025 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Johnson & Johnson JNJ | Aug 14, 2025 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Merck MRK Stock | Aug 14, 2025 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | Julie Johnson DHouseTexas-32 | ↓sold | AbbVie ABBV | Aug 14, 2025 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 14, 2025 10mo ago | Julie Johnson DHouseTexas-32 | ↑bought | Merck MRK Stock | Jun 13, 2025 31 days to disclose | Good buy·+$3.1K+39.0% +29.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Julie Johnson DHouseTexas-32 | ↓sold | Eli Lilly LLY | Apr 7, 2025 37 days to disclose | Flat·+0.0% +10.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Julie Johnson DHouseTexas-32 | ↓sold | Johnson & Johnson JNJ | Apr 1, 2025 43 days to disclose | Flat·+0.0% +3.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Julie Johnson DHouseTexas-32 | ↓sold | Bristol-Myers Squibb BMY Common Stock | Apr 1, 2025 43 days to disclose | Flat·+0.0% +3.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Julie Johnson DHouseTexas-32 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Apr 1, 2025 43 days to disclose | Flat·+0.0% +3.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Julie Johnson DHouseTexas-32 | ↓sold | Zoetis ZTS | Apr 1, 2025 43 days to disclose | Flat·+0.0% +3.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | Julie Johnson DHouseTexas-32 | ↓sold | Zoetis ZTS | Mar 3, 2025 42 days to disclose | Flat·+0.0% −0.7% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2025 1.2y ago | Julie Johnson DHouseTexas-32 | ↓sold | Pfizer PFE Pfizer, Inc. | Feb 24, 2025 16 days to disclose | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2025 1.2y ago | Julie Johnson DHouseTexas-32 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Feb 12, 2025 28 days to disclose | Flat·+0.0% +1.8% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 12, 2025 1.3y ago | Julie Johnson DHouseTexas-32 | ↑bought | Merck MRK Stock | Jan 17, 2025 26 days to disclose | Good buy·+$1.3K+16.0% +10.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 12, 2025 1.3y ago | Julie Johnson DHouseTexas-32 | ↑bought | Bristol-Myers Squibb BMY Common Stock | Jan 15, 2025 28 days to disclose | Bad buy·−$207-2.6% −8.2% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 12, 2025 1.3y ago | Julie Johnson DHouseTexas-32 | ↑bought | Regeneron Pharmaceuticals REGN Common Stock | Jan 15, 2025 28 days to disclose | Good buy·+$200+2.5% −3.1% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 12, 2025 1.3y ago | Julie Johnson DHouseTexas-32 | ↓sold | Moderna MRNA | Jan 15, 2025 28 days to disclose | Flat·+0.0% +5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 12, 2025 1.3y ago | Julie Johnson DHouseTexas-32 | ↓sold | Pfizer PFE Pfizer, Inc. | Jan 13, 2025 30 days to disclose | Flat·+0.0% +5.0% vs S&P 500 | $1K-$15K midpoint $8K |